Published in Curr Opin Immunol on August 01, 1999
P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II. Mol Cell Biol (2000) 5.64
The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation. EMBO J (2001) 3.80
Genome-wide analysis of chromosomal features repressing human immunodeficiency virus transcription. J Virol (2005) 3.51
MAQ1 and 7SK RNA interact with CDK9/cyclin T complexes in a transcription-dependent manner. Mol Cell Biol (2003) 2.90
Spt5 and spt6 are associated with active transcription and have characteristics of general elongation factors in D. melanogaster. Genes Dev (2000) 2.78
Evidence that negative elongation factor represses transcription elongation through binding to a DRB sensitivity-inducing factor/RNA polymerase II complex and RNA. Mol Cell Biol (2002) 2.59
A block to human immunodeficiency virus type 1 assembly in murine cells. J Virol (2000) 2.47
Human transcription elongation factor NELF: identification of novel subunits and reconstitution of the functionally active complex. Mol Cell Biol (2003) 2.21
CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 tat-P-TEFb complex to TAR RNA. Mol Cell Biol (2000) 1.89
Spt5 cooperates with human immunodeficiency virus type 1 Tat by preventing premature RNA release at terminator sequences. Mol Cell Biol (2002) 1.82
Recruitment of TFIIH to the HIV LTR is a rate-limiting step in the emergence of HIV from latency. EMBO J (2006) 1.68
Interaction between P-TEFb and the C-terminal domain of RNA polymerase II activates transcriptional elongation from sites upstream or downstream of target genes. Mol Cell Biol (2002) 1.68
The transcription elongation factor CA150 interacts with RNA polymerase II and the pre-mRNA splicing factor SF1. Mol Cell Biol (2001) 1.64
Tat gets the "green" light on transcription initiation. Retrovirology (2005) 1.61
Mouse-human heterokaryons support efficient human immunodeficiency virus type 1 assembly. J Virol (2001) 1.55
HIV-1 Tat stimulates transcription complex assembly through recruitment of TBP in the absence of TAFs. PLoS Biol (2005) 1.50
Transcriptional synergy between Tat and PCAF is dependent on the binding of acetylated Tat to the PCAF bromodomain. EMBO J (2002) 1.49
Induction of TAK (cyclin T1/P-TEFb) in purified resting CD4(+) T lymphocytes by combination of cytokines. J Virol (2001) 1.48
A nucleolar TAR decoy inhibitor of HIV-1 replication. Proc Natl Acad Sci U S A (2002) 1.39
HIV-1 gene expression: lessons from provirus and non-integrated DNA. Retrovirology (2004) 1.36
Transient induction of cyclin T1 during human macrophage differentiation regulates human immunodeficiency virus type 1 Tat transactivation function. J Virol (2002) 1.29
Recruitment of human cyclin T1 to nuclear bodies through direct interaction with the PML protein. EMBO J (2003) 1.26
Defining the chromatin signature of inducible genes in T cells. Genome Biol (2009) 1.15
Antiapoptotic function of Cdk9 (TAK/P-TEFb) in U937 promonocytic cells. J Virol (2001) 1.14
Chromatin reassembly factors are involved in transcriptional interference promoting HIV latency. J Virol (2011) 1.10
Integrated self-inactivating lentiviral vectors produce full-length genomic transcripts competent for encapsidation and integration. J Virol (2004) 1.06
Cyclin T1-dependent genes in activated CD4 T and macrophage cell lines appear enriched in HIV-1 co-factors. PLoS One (2008) 1.01
Human immunodeficiency virus type 1 infection induces cyclin T1 expression in macrophages. J Virol (2004) 0.99
Association of Tat with promoters of PTEN and PP2A subunits is key to transcriptional activation of apoptotic pathways in HIV-infected CD4+ T cells. PLoS Pathog (2010) 0.99
TRIM5α and Species Tropism of HIV/SIV. Front Microbiol (2012) 0.96
The positive transcription elongation factor b is an essential cofactor for the activation of transcription by myocyte enhancer factor 2. J Mol Biol (2008) 0.93
Nuclear import of the preintegration complex is blocked upon infection by human immunodeficiency virus type 1 in mouse cells. J Virol (2006) 0.93
Endogenous MCM7 microRNA cluster as a novel platform to multiplex small interfering and nucleolar RNAs for combinational HIV-1 gene therapy. Hum Gene Ther (2012) 0.86
Recognition of 5'-terminal TAR structure in human immunodeficiency virus-1 mRNA by eukaryotic translation initiation factor 2. Nucleic Acids Res (2000) 0.84
NF-kappaB-repressing factor inhibits elongation of human immunodeficiency virus type 1 transcription by DRB sensitivity-inducing factor. Mol Cell Biol (2005) 0.81
Estrogen receptor alpha inhibits the estrogen-mediated suppression of HIV transcription in astrocytes: implications for estrogen neuroprotection in HIV dementia. AIDS Res Hum Retroviruses (2009) 0.80
Anti-viral opportunities during transcriptional activation of latent HIV in the host chromatin. Methods (2010) 0.79
HIV-1 Tat second exon limits the extent of Tat-mediated modulation of interferon-stimulated genes in antigen presenting cells. Retrovirology (2014) 0.79
Tripartite Motif-Containing Protein 22 Interacts with Class II Transactivator and Orchestrates Its Recruitment in Nuclear Bodies Containing TRIM19/PML and Cyclin T1. Front Immunol (2017) 0.75
Two distinct transcription factors bind to the HSV thymidine kinase promoter in vitro. Cell (1985) 11.03
A cellular DNA-binding protein that activates eukaryotic transcription and DNA replication. Cell (1987) 10.22
A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell (1998) 10.14
Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1. Science (1986) 8.01
The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes Dev (1998) 4.38
A thymus-specific member of the HMG protein family regulates the human T cell receptor C alpha enhancer. Genes Dev (1991) 4.25
Sp1 binds to promoter sequences and activates herpes simplex virus 'immediate-early' gene transcription in vitro. Nature (1985) 3.99
Trace amines: identification of a family of mammalian G protein-coupled receptors. Proc Natl Acad Sci U S A (2001) 3.23
Essential contact residues within SV40 large T antigen binding sites I and II identified by alkylation-interference. Cell (1984) 2.59
Two distinct nuclear transcription factors recognize loop and bulge residues of the HIV-1 TAR RNA hairpin. Genes Dev (1991) 2.49
Inhibition of axonal growth by SNAP-25 antisense oligonucleotides in vitro and in vivo. Nature (1993) 2.43
In vitro formation of short RNA polymerase II transcripts that terminate within the HIV-1 and HIV-2 promoter-proximal downstream regions. Genes Dev (1989) 2.36
Histone acetyltransferases regulate HIV-1 enhancer activity in vitro. Genes Dev (1997) 2.25
Purification of TCF-1 alpha, a T-cell-specific transcription factor that activates the T-cell receptor C alpha gene enhancer in a context-dependent manner. New Biol (1990) 2.21
In vitro activation of the HIV-1 enhancer in extracts from cells treated with a phorbol ester tumor promoter. EMBO J (1987) 2.09
Functional selectivity of recombinant mammalian SWI/SNF subunits. Genes Dev (2000) 2.07
NF-kappa B-mediated chromatin reconfiguration and transcriptional activation of the HIV-1 enhancer in vitro. Genes Dev (1996) 2.07
Activation of the HIV-1 enhancer by the LEF-1 HMG protein on nucleosome-assembled DNA in vitro. Genes Dev (1995) 2.07
The hLEF/TCF-1 alpha HMG protein contains a context-dependent transcriptional activation domain that induces the TCR alpha enhancer in T cells. Genes Dev (1993) 2.04
Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice. J Clin Invest (1999) 2.02
Prediction of femoral fracture load using automated finite element modeling. J Biomech (1998) 1.99
GABAB receptors - the first 7TM heterodimers. Trends Pharmacol Sci (1999) 1.94
Tat-associated kinase, TAK, activity is regulated by distinct mechanisms in peripheral blood lymphocytes and promonocytic cell lines. J Virol (1998) 1.93
CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 tat-P-TEFb complex to TAR RNA. Mol Cell Biol (2000) 1.89
Trans-activation by human immunodeficiency virus Tat protein requires the C-terminal domain of RNA polymerase II. Proc Natl Acad Sci U S A (1996) 1.68
Distinct roles for P-CREB and LEF-1 in TCR alpha enhancer assembly and activation on chromatin templates in vitro. Genes Dev (1997) 1.65
Chromatin-specific regulation of LEF-1-beta-catenin transcription activation and inhibition in vitro. Genes Dev (2001) 1.48
Identification and characterization of two G protein-coupled receptors for neuropeptide FF. J Biol Chem (2000) 1.41
Cloning of an SNF2/SWI2-related protein that binds specifically to the SPH motifs of the SV40 enhancer and to the HIV-1 promoter. J Biol Chem (1995) 1.35
Friction in airway smooth muscle: mechanism, latch, and implications in asthma. J Appl Physiol (1985) (1996) 1.34
Mutational analysis of simian virus 40 large T antigen DNA binding sites. EMBO J (1984) 1.31
Comparison of two murine models of familial hypertrophic cardiomyopathy. Circ Res (2001) 1.30
HIV-1 Tat interacts with cyclin T1 to direct the P-TEFb CTD kinase complex to TAR RNA. Cold Spring Harb Symp Quant Biol (1998) 1.29
HIV-1 TAR RNA enhances the interaction between Tat and cyclin T1. J Biol Chem (2000) 1.26
Functional properties of a cloned 5-hydroxytryptamine ionotropic receptor subunit: comparison with native mouse receptors. J Physiol (1994) 1.26
Home monitoring of transcutaneous oxygen tension in the early detection of hypoxaemia in infants and young children. Arch Dis Child (1991) 1.23
Cloned human and rat galanin GALR3 receptors. Pharmacology and activation of G-protein inwardly rectifying K+ channels. J Biol Chem (1998) 1.18
Expression cloning of a rat hypothalamic galanin receptor coupled to phosphoinositide turnover. J Biol Chem (1997) 1.13
HIV-1 core promoter lacks a simple initiator element but contains a bipartite activator at the transcription start site. J Biol Chem (1993) 1.13
Prediction of fracture location in the proximal femur using finite element models. Med Eng Phys (2001) 1.13
Hyperkinetic borderline hypertension in Tecumseh, Michigan. J Hypertens (1991) 1.10
A neural network predicts progression for men with gleason score 3+4 versus 4+3 tumors after radical prostatectomy. Urology (2000) 1.10
Control of interneuron dendritic growth through NRG1/erbB4-mediated kalirin-7 disinhibition. Mol Psychiatry (2011) 1.09
31P NMR saturation-transfer measurements in Saccharomyces cerevisiae: characterization of phosphate exchange reactions by iodoacetate and antimycin A inhibition. Biochemistry (1987) 1.05
Regulation of BRCA1. Nature (1995) 1.04
D2, D3, and D4 dopamine receptors couple to G protein-regulated potassium channels in Xenopus oocytes. Mol Pharmacol (1996) 0.99
Cell-specific expression of group X and group V secretory phospholipases A(2) in human lung airway epithelial cells. Am J Respir Cell Mol Biol (2000) 0.97
(2S,4R)-4-methylglutamic acid (SYM 2081): a selective, high-affinity ligand for kainate receptors. J Pharmacol Exp Ther (1997) 0.97
Role of protein kinase C in calcium sensitization during muscarinic stimulation in airway smooth muscle. Am J Physiol (1997) 0.95
Genetically engineered neural networks for predicting prostate cancer progression after radical prostatectomy. Urology (1999) 0.90
Halothane attenuates calcium sensitization in airway smooth muscle by inhibiting G-proteins. Anesthesiology (1998) 0.89
cGMP-independent mechanism of airway smooth muscle relaxation induced by S-nitrosoglutathione. Am J Physiol (1998) 0.88
Cortical neurons containing calretinin are selectively resistant to calcium overload and excitotoxicity in vitro. Neuroscience (1994) 0.88
Cloning and characterization of the human galanin GALR2 receptor. Peptides (1998) 0.87
Pharmacological characterization of a novel positive modulator at alpha 4 beta 3 delta-containing extrasynaptic GABA(A) receptors. Neuropharmacology (2010) 0.86
Organization of the mouse 5-HT3 receptor gene and functional expression of two splice variants. Brain Res Mol Brain Res (1994) 0.86
Physical mapping, cloning, and identification of genes within a 500-kb region containing BRCA1. Proc Natl Acad Sci U S A (1995) 0.85
Induction of heat shock proteins by canavanine in Tetrahymena. No change in ATP levels measured in vivo by NMR. J Biol Chem (1986) 0.85
Reversibility characteristics of glucose-induced trehalase activation associated with the breaking of dormancy in yeast ascospores. Eur J Biochem (1983) 0.85
In vivo 31P nuclear magnetic resonance saturation transfer measurements of phosphate exchange reactions in the yeast Saccharomyces cerevisiae. FEBS Lett (1985) 0.84
Calcium concentration-dependent mechanisms through which ketamine relaxes canine airway smooth muscle. Anesthesiology (1997) 0.84
Biological actions of oncogenes. Pharmacol Ther (1993) 0.83
Molecular modelling and site-directed mutagenesis of human GALR1 galanin receptor defines determinants of receptor subtype specificity. Protein Eng (2002) 0.83
Substituted 1,2-dihydrophthalazines: potent, selective, and noncompetitive inhibitors of the AMPA receptor. J Med Chem (1996) 0.83
The strain variation and virulence of granulovirus of diamondback moth (Plutella xylostella Linnaeus, Lep., Yponomeutidae) isolated in Kenya. J Invertebr Pathol (2002) 0.82
Clinical evaluation comparing AxSYM CA 15-3, IMx CA 15-3 and Truquant BRTM RIA. Tumour Biol (1998) 0.81
Cross-bridge cycling kinetics, actomyosin ATPase activity and myosin heavy chain isoforms in skeletal and smooth respiratory muscles. Comp Biochem Physiol B Biochem Mol Biol (1998) 0.81
Efficacy trials with tissue-culture grown, inactivated vaccines against chlamydial abortion in sheep. Vaccine (1995) 0.81
Effects of intravenous anesthetics on Ca2+ sensitivity in canine tracheal smooth muscle. Anesthesiology (2000) 0.81
An in situ hybridization study of the distribution of the GABA(B2) protein mRNA in the rat CNS. Brain Res Mol Brain Res (1999) 0.81
The effects of ethanol on CA(2+) sensitivity in airway smooth muscle. Anesth Analg (2001) 0.80
Calcium sensitization produced by G protein activation in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol (2001) 0.80
The Tecumseh Blood Pressure Study. Normative data on blood pressure self-determination. Arch Intern Med (1990) 0.79
The in vivo production of Spodoptera littoralis nuclear polyhedrosis virus. J Virol Methods (1998) 0.79
Protein and RNA affinity selection techniques using HIV-1 Tat. Methods Enzymol (1999) 0.79
A versatile, computer-controlled, closed-loop system for continuous infusion of muscle relaxants. Mayo Clin Proc (1993) 0.78
Effect of halothane on intracellular calcium oscillations in porcine tracheal smooth muscle cells. Am J Physiol (1999) 0.78
Hydrogen peroxide decreases Ca(2+) sensitivity in airway smooth muscle by inhibiting rMLC phosphorylation. Am J Physiol (1999) 0.78
Differential backfilling of interneuron populations based upon axon projections in a lobster abdominal ganglion. J Neurobiol (1983) 0.78
The HIP116 SNF2/SW12-related transcription factor gene (SNF2L3) is located on human chromosome 3q25.1-q26.1. Genomics (1995) 0.78
Relationship between force and regulatory myosin light chain phosphorylation in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol (2000) 0.78
The role of free/total prostate-specific antigen ratio in the prediction of final pathologic stage for men with clinically localized prostate cancer. Urology (1996) 0.78
Halothane attenuation of calcium sensitivity in airway smooth muscle. Mechanisms of action during muscarinic receptor stimulation. Anesthesiology (1997) 0.78
Postural interneurons in the abdominal nervous system of lobster. I. Organization, morphologies and motor programs for flexion, extension and inhibition. J Comp Physiol A (1986) 0.78
The role of cGMP in the relaxation to nitric oxide donors in airway smooth muscle. Eur J Pharmacol (1998) 0.77
Use of nitric oxide-nucleophile adducts as biological sources of nitric oxide: effects on airway smooth muscle. J Pharmacol Exp Ther (1996) 0.77
Effect of phorbol esters on Ca2+ sensitivity and myosin light-chain phosphorylation in airway smooth muscle. Am J Physiol (1998) 0.77
Technical evaluation of five glucose meters with data management capabilities. Am J Clin Pathol (1999) 0.77
Halothane and potassium channels in airway smooth muscle. Br J Anaesth (1996) 0.77
Antisense Blockade of Expression : SNAP-25 In Vitro and In Vivo. Methods Mol Med (1996) 0.76
S-nitrosoglutathione-induced decrease in calcium sensitivity of airway smooth muscle. Am J Physiol Lung Cell Mol Physiol (2000) 0.76
Stereospecific effects of ketamine enantiomers on canine tracheal smooth muscle. Br J Pharmacol (1997) 0.76
Chemicals that footprint DNA: hitting HIV-1 in the minor groove. Proc Natl Acad Sci U S A (1998) 0.76
Outreach teachers essential. Br Dent J (2017) 0.75
Chronic organic manganese administration in the rat does not damage dopaminergic nigrostriatal neurons. Neurotoxicology (1986) 0.75
Taking out Tat. Nat Biotechnol (1996) 0.75
Method of intraoperative monitoring of neuromuscular function and residual blockade in the recovery room. Minn Med (1992) 0.75
Postural interneurons in the abdominal nervous system of lobster. III. Pathways mediating intersegmental spread of excitation. J Comp Physiol A (1986) 0.75
Postural interneurons in the abdominal nervous system of lobster. II. Evidence for neurons having both command and driver roles. J Comp Physiol A (1986) 0.75
Factors influencing the direct actions of volatile anesthetics on airway smooth muscle. Anesthesiology (1993) 0.75